$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Novartis AG (NYSE:NVS) Shares Sold by Narwhal Capital Management
05:42pm, Tuesday, 07'th Dec 2021 Dakota Financial News
Narwhal Capital Management trimmed its position in Novartis AG (NYSE:NVS) by 18.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 69,938 shares of the companys stock after selling 16,159 shares during the period. Narwhal Capital Managements holdings in Novartis were []
Cascade Investment Advisors Inc. Has $1.84 Million Position in Novartis AG (NYSE:NVS)
03:04pm, Tuesday, 07'th Dec 2021 Transcript Daily
Cascade Investment Advisors Inc. lifted its holdings in shares of Novartis AG (NYSE:NVS) by 4.2% in the 3rd quarter, HoldingsChannel reports. The fund owned 22,470 shares of the companys stock after purchasing an additional 900 shares during the period. Novartis makes up approximately 1.2% of Cascade Investment Advisors Inc.s investment portfolio, making the stock its []
CAR-T Therapy Market 2021 Analysis by Leading Key Players Novartis AG, Kite Pharm, Pfizer Inc, Juno Therapeutic, Celgene Corporation
11:44am, Tuesday, 07'th Dec 2021 OpenPR
The CAR-T Therapy market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an
Global Vaccines Market Size [2021-2028] | to Reach USD 104.87 Billion and Exhibit a Stellar CAGR of 10.7%
08:42am, Tuesday, 07'th Dec 2021 Intrado Digital Media
Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players. Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players.
Medicine of Bioengineered Protein Market Notable Growth in CAGR +8% by end 2027|| GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche
08:02am, Tuesday, 07'th Dec 2021 OpenPR
A Proteins play a crucial role in preserving both the physical and practical aspects of a specific creature. Long-chain of amino acids brands up a protein element and controls all biological functions such as metabolic responses, DNA repetition, and other
Bryan, Garnier & Co Reiterates Neutral Rating for Novartis (NYSE:NVS)
06:58am, Tuesday, 07'th Dec 2021 Dakota Financial News
Bryan, Garnier & Co restated their neutral rating on shares of Novartis (NYSE:NVS) in a research note released on Friday, Price Targets.com reports. The firm currently has a $85.00 target price on the stock, down from their previous target price of $115.00. Several other equities analysts have also recently commented on the company. Berenberg Bank []
Nano-Drug Market 2021 Huge Growth Opportunities and Trends to 2027 |Merck, Pfizer, Novartis, Abbott
04:48am, Tuesday, 07'th Dec 2021 OpenPR
Global Nano-Drug Sales Market Report 2021 The Nano-Drug Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed
Novartis eyes pan coronavirus oral therapy - CEO
08:03pm, Monday, 06'th Dec 2021 Seeking AlphaRoche completes repurchase of $53.3M shares from Novartis
05:56pm, Monday, 06'th Dec 2021 Seeking AlphaKisumu to launch sickle cell management unit
05:48pm, Monday, 06'th Dec 2021 Kenyan News
A sickle cell disease management and care project is set to be launched on Tuesday at the Jaramogi Oginga Odinga Teaching and Referral Hospital. This will aid in responding to the high burden of the condition in the region. The project is a partnership between Novartis East Africa and the Kisumu county government. The project [] Source: Kisumu to launch sickle cell management unit
Company Spin-Offs And Adjusted (ADJ) Options
05:07pm, Monday, 06'th Dec 2021 INO
Occasionally, businesses undergo corporate restructuring for various reasons. Often this involves spinning off a separate, independent entity to potentially unlock value for shareholders over the long term. Some notable spin-offs include Dow from DowDuPont, Alcon from Novartis, Otis Elevators from United Technologies, and VMWare from Dell. When company spin-offs occur during an options expiration cycle, []
F. Hoffmann-La Roche Ltd: Roche completed the repurchase of Roche shares from Novartis
04:53pm, Monday, 06'th Dec 2021 FinanzNachrichten
Basel, 6 December 2021 - Roche.All trademarks used or mentioned in this release are protected by law.Roche Group Media RelationsPhone: +41 61 688 8888 / e-mail: [email protected] Dr. Nicola
Novartis AG (NYSE:NVS) Shares Bought by Patriot Investment Management Inc.
02:40pm, Monday, 06'th Dec 2021 Transcript Daily
Patriot Investment Management Inc. grew its position in Novartis AG (NYSE:NVS) by 4.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,140 shares of the companys stock after buying an additional 231 shares during the quarter. Patriot Investment []
Neurodegenerative Disease Market Recent Trends, Future Growth Analysis Forecasts 2027| Novartis, Pfizer, Merck Serono, Biogen Idec
12:23pm, Monday, 06'th Dec 2021 OpenPR
The global Neurodegenerative Disease market size is projected a CAGR of 3.4% during 2021-2027. The rising frequency of neurological illnesses, more public awareness, and a robust product pipeline for neurodegenerative disease treatment are all driving the growth of the neurodegenerative
Narcotic Analgesics Market with Attractiveness, Competitive Landscape & Forecasts to 2027| Sanofi S.A., Novartis AG, GlaxoSmithKline PLC
12:17pm, Monday, 06'th Dec 2021 OpenPR
The global Narcotic Analgesics market size is projected a CAGR of 4.6% during 2021-2027. The ageing population''s frequent pain and aches, rising incidences of cardiovascular disease (CVD), cancer, and arthritis, and rising public and private sector R&D spending, with a
Sign In
Buy NVS